Article Date: Thursday 24 09 09 13:50 UTC
Full Article: Influenza A(H1N1)
Regulatory authorities have licensed pandemic vaccines in Australia, China and the United States of America, soon to be followed by Japan and several countries in Europe. The length of the approval process depends on factors such as each country's regulatory pathway, the type of vaccine being licensed, and the stage of manufacturers' readiness to submit appropriate information to regulatory authorities.
|
|
Bookmark with: